HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor

Kovacs, Jeffrey J., Murphy, Patrick J.M., Gaillard, Stéphanie, Zhao, Xuan, Wu, June-Tai, Nicchitta, Christopher V., Yoshida, Minoru, Toft, David O. +2 more·2005·Molecular Cell
DOI 10.1016/j.molcel.2005.04.021

Cited by (1,001)

Items 801–900 of 1,001

  1. Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy
    Jason C. Wong, Lei Guo, Zhenghong Peng, Weixing Zhang, Nan Zhang, Wayne Lai, Zhenshan Zhang, Chao Zhang, Xiongwen Zhang, Shan Song et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
  2. Nitrotyrosine impairs mitochondrial function in fetal lamb pulmonary artery endothelial cells
    Ru‐Jeng Teng, Tzong-Jin Wu, Adeleye James Afolayan, Girija Ganesh Konduri · 2015 · American Journal of Physiology-Cell Physiology
  3. The regulation and function of the heat shock response
    Eric Guisbert, Richard I. Morimoto · 2012 · Research and perspectives in Alzheimer's disease
  4. X-ray crystal structures, density functional theory and docking on deacetylase enzyme for antiproliferative activity of hispolon derivatives on HCT116 colon cancer
    Miriam Rossi, Francesco Caruso, Ilaria Costanzini, Carmen Kloer, Aron Sulovari, Elena Monti, Marzia Bruna Gariboldi, Emanuela Marras, Neduri V. Balaji, Modukuri V. Ramani et al. · 2019 · Bioorganic & Medicinal Chemistry
  5. Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia Activity
    Marc Pflieger, Melf Sönnichsen, Nadine Horstick‐Muche, Jing Chun Yang, Julian Schliehe‐Diecks, Andrea Schöler, Arndt Borkhardt, Alexandra Hamacher, Matthias Ulrich Kassack, Finn K. Hansen et al. · 2021 · ChemMedChem
  6. A cell-based screen for inhibitors of protein folding and degradation
    Frank Boschelli, Jennifer M. Golas, Roseann Petersen, Vincent Lau, Lei Chen, Diane Tkach, Qiang Zhao, Dave S. Fruhling, Hao Liu, Chan-Eun Nam et al. · 2010 · Cell Stress and Chaperones
  7. Histone Deacetylase Inhibitors in the Therapy of Cancer: Much to Learn
    Ju‐Hee Lee, Paul A. Marks · 2010 · Epigenomics
  8. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia
    Sandeep Pandey, Ranjana Singh, Nimra Habib, Ramesh Tripathi, Rashmi Kushwaha, Abbas Ali Mahdi · 2024 · Asian Pacific Journal of Cancer Prevention
  9. Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review)
    Fei Qu, Qingqing Zhao, Yi Jin · 2025 · International Journal of Molecular Medicine
  10. The Potential of Histone Deacetylase Inhibitors in Breast Cancer Therapy
    Namita Chatterjee, Martin Tenniswood · 2015 · Breast Cancer Management
  11. Hsp90 chaperone facilitates E2F1/2-dependent gene transcription in human breast cancer cells
    Akhil Kotwal, Sourabh Suran, Sreedhar Amere Subbarao · 2020 · European Journal of Cell Biology
  12. Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk
    Mikel Allende, Eva Molina, Ramón Lecumberri, Juan Antonio Sánchez-Arias, Ana Ugarte, Elizabeth Guruceaga, Julen Oyarzábal, José Hermida · 2017 · Thrombosis and Haemostasis
  13. Glucocorticoid receptor isoform expression in peripheral blood mononuclear leukocytes of patients with chronic rhinosinusitis
    Robert Taylor, Rodney J. Schlosser, Zachary M. Soler, José L. Mattos, Jennifer Konopa Mulligan · 2018 · International Forum of Allergy & Rhinology
  14. Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and views
    S. M. Hejazian, Sepideh Zununi Vahed, Hakimeh Moghaddas Sani, Ziba Nariman-Saleh-Fam, M. Bastami, S. M. Hosseiniyan Khatibi, M. Ardalan, N. Samadi · 2019 · Expert Review of Clinical Pharmacology
  15. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells
    Na Wang, Hua Wang, Jianming Chen, Fubin Wang, Shuaiyi Wang, Qiang Zhou, Jichong Ying, Shanzhao Huang, Pu Wang, Fangfang Yuan · 2020 · Molecular Medicine Reports
  16. Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer
    Luisa Salvatori, Francesco Spallotta, Carlo Gaetano, Barbara Illi · 2021 · Life
  17. Inhibiteurs des histone-désacétylases : la régulation épigénétique sort de l’ombre
    Nicolas Pécuchet, Thomas Cluzeau, Constance Thibault, Nicolas Mounier, Stéphane Vignot · 2010 · Bulletin du Cancer
  18. Functional interplay between cylindromatosis and histone deacetylase 6 in ciliary homeostasis revealed by phenotypic analysis of double knockout mice
    Jie Ran, Fan Dong Yu, Juan Qin, Yijun Zhang, Yunfan Yang, Dengwen Li, Jun Zhou, Min Liu · 2016 · Oncotarget
  19. HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells
    Gregory W. Watson, Samanthi I. Wickramasekara, Yufeng “Francis” Fang, Claudia S. Maier, David E Williams, Roderick H. Dashwood, Viviana Pérez, Emily Ho · 2015 · Experimental Biology and Medicine
  20. The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities
    Hong-wei Li, Haihong Zhang · 2024 · International Journal of Medical Sciences
  21. HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP/PS1 transgenic mice through HSP90-HSF1 pathway
    Bingyi Wang, Siyu Liu, Kai-Min Hao, YaruWang Wang, Zongjing Li, Yuanyuan Lou, Yuan Chang, Wenxiu Qi · 2024 · Experimental Brain Research
  22. Histone deacetylase’s regulates Tau function in Alzheimer’s disease
    Subashchandrabose Chinnathambi · 2024 · Advances in protein chemistry and structural biology
  23. The Influence of Different Light Spectra on Broiler Chicken Endocrine Systems and Productivity
    Lenuța Galan, Gheorghe Solcan, Carmen Solcan · 2025 · Animals
  24. HDAC6 Triggers the ATM-Dependent DNA Damage Response To Promote PRV Replication
    Weiyin Xu, Ping Yan, Ziyan Zhou, Jingting Yao, Haochun Pan, Luyao Jiang, Zongyi Bo, Bo Ni, Mingxia Sun, Song Gao et al. · 2023 · Microbiology Spectrum
  25. HDAC6 and ERK/ADAM17 Regulate VEGF-Induced NOTCH Signaling in Lung Endothelial Cells
    Sheng Xia, Heather L. Menden, Sherry M. Mabry, Venkatesh Sampath · 2023 · Cells
  26. Analyzing Gene Expression Profile in K562 Cells Exposed to Sodium Valproate Using Microarray Combined with the Connectivity Map Database
    Xiangzhong Zhang, Aihua Yin, Dong-Jun Lin, Xiaoyu Zhu, Qian Ding, Chunhuai Wang, Yunxian Chen · 2012 · BioMed Research International
  27. The nature of the GRE influences the screening for GR-activity enhancing modulators
    Karen Dendoncker, Steven Timmermans, Kelly Van Looveren, Lode De Cauwer, Karolien De Bosscher, Claude Libert · 2017 · PLoS ONE
  28. Measuring the Effect of Histone Deacetylase Inhibitors (HDACi) on the Secretion and Activity of Alpha-1 Antitrypsin
    Chao Wang, Marion Bouchecareilh, William E. Balch · 2017 · Methods in molecular biology
  29. Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer
    Mari Ishigami‐Yuasa, HISAO EKIMOTO, Hiroyuki Kagechika · 2019 · Biological and Pharmaceutical Bulletin
  30. Novel HDAC6 selective inhibitors with 4-aminopiperidine-1- carboxamide as the core structure enhanced growth inhibitory activity of bortezomib in MCF-7 cells
    Chenru Zhao, Jianjun Gao, Li Zhang, Li Su, Yepeng Luan · 2019 · BioScience Trends
  31. Histone deacetylase 6 inhibition improves survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia
    Ben E. Biesterveld, Glenn K. Wakam, Michael T. Kemp, Aaron M. Williams, Alizeh Shamshad, Rachel L. O’Connell, Ali Z. Siddiqui, Kiril Chtraklin, Umar Farooq Bhatti, Yongqing Li et al. · 2020 · The Journal of Trauma: Injury, Infection, and Critical Care
  32. Hsp90 regulates HDAC3-dependent gene transcription while HDAC3 regulates the functions of Hsp90
    Akhil Kotwal, Sreedhar Amere Subbarao · 2020 · Cellular Signalling
  33. HDAC6 regulates human erythroid differentiation through modulation of JAK2 signalling
    Pascal Vong, Kahia Messaoudi, Nicolas Jankovsky, Cathy Gomilla, Yohann Demont, Alexis Caulier, Guillaume Jedraszak, Julien Demagny, Stefan Djordjevic, Thomas Boyer et al. · 2022 · Journal of Cellular and Molecular Medicine
  34. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status
    Tae Hyun Kim, Choung‐Soo Kim, Je‐Hwan Lee, Se Jin Jang, Jung Jin Hwang, Seonggu Ro, Young‐Lan Hyun, Jene Choi · 2010 · Breast Cancer Research and Treatment
  35. Investigation of the Cross-talk Mechanism in Caco-2 Cells during Clostridium difficile Infection through Genetic-and-Epigenetic Interspecies Networks: Big Data Mining and Genome-Wide Identification
    Chengwei Li, Ming-He Su, Bor‐Sen Chen · 2017 · Frontiers in Immunology
  36. Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway
    Stephen Kershaw, David J. Morgan, James Boyd, David G. Spiller, Gareth B. Kitchen, Egor Zindy, Mudassar Iqbal, Magnus Rattray, Christopher M. Sanderson, Andy Brass et al. · 2020 · Journal of Cell Science
  37. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6)
    Miao Li, Yan Zhuang, Bin Shan · 2016 · Methods in molecular biology
  38. ATAT1 is essential for regulation of homeostasis-retaining cellular responses in corticotrophs along hypothalamic-pituitary-adrenal axis
    Takashi Nakakura, Takeshi Suzuki, Seiji Torii, Anshin Asano-Hoshino, Yoko Nekooki-Machida, Hideyuki Tanaka, Kenjiro Arisawa, Yoshimi Nishijima, Takao Susa, Tomoki Okazaki et al. · 2017 · Cell and Tissue Research
  39. Potentiometric flow-injection determination of vitamin C and glutathione with a chemically prepared tubular silver electrode.
    Mitja Kolar, Danilo Dobčnik, N Radić · 2000 · PubMed
  40. Integrated molecular modeling and dynamics approaches revealed the mechanism of selective inhibition of HDAC6/8
    Yaxin Li, Sisi Liu, Ximing Xu, Jiamin Xu, Leifu Yang, Liming Hu · 2023 · Journal of Biomolecular Structure and Dynamics
  41. Inhibition of HSP90AA1 induces abnormalities in bovine oocyte maturation and embryonic development
    Baobao Zhao, Heqiang Li, Han Zhang, Xinrui Lan, Xingchen Ren, Liangyi Zhang, Huiming Ma, Yong Zhang, Yongsheng Wang · 2024 · Reproduction
  42. FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation
    Dake Xiao, Haowen Ran, Lishu Chen, Yuanyuan Li, Yan Cai, Songyang Zhang, Qinghui Qi, Huiran Wu, Cheng Zhang, Shuailiang Cao et al. · 2025 · Science China Life Sciences
  43. Integrating deep learning for post-translational modifications crosstalk on Hsp90 and drug binding
    Jennifer A. Heritz, Katherine A. Meluni, Sarah J. Backe, Sara J Cayaban, Laura A. Wengert, Meik Kunz, Mark R. Woodford, Dimitra Bourboulia, Mehdi Mollapour · 2025 · Journal of Biological Chemistry
  44. Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function
    Xingzhi Peng, Peijun Zhou, Kun Zhang, Likang Chen, Min Tang, Qin Zhou, Jinwu Peng, Lifang Yang · 2025 · Cell Death and Disease
  45. Regulation of apoptosis, ferroptosis, and pyroptosis mediated by acetylation
    Weijie Lu, Yaoting Deng, Mengyang Liu, Yujie Hu, Kang Yang, Bowen Wang, Yanling Li, gang wang, Li Ma, JIA LIU et al. · 2026 · Cell Death Discovery
  46. Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications
    Xueyi Wang, Ruiqing Ni, Xiaohui Wang, Xun Li · 2026 · Molecular Cancer
  47. Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?
    Stefan N. Constantinescu, William Vainchenker · 2012 · Hematology
  48. Post-translational modifications and age-related hearing loss
    Parveen Bazard, Jennifer Pineros, Alejandro A. Acosta, Mark Thivierge, Lauren R. Paganella, Samuel Zucker, Freyda L. Mannering, Shrikar P. Modukuri, Xiaoxia Zhu, Robert D. Frisina et al. · 2022 · Hearing Research
  49. A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines
    Kendric Wang, Raunak Shrestha, Alexander William Wyatt, Anupama Reddy, Joseph Lehár, Yuzhou Wang, Anna V. Lapuk, Colin C. Collins · 2014 · PLoS ONE
  50. Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity
    Sarah J. Backe, Mark R. Woodford, Elham F. Ahanin, Rebecca Sager, Dimitra Bourboulia, Mehdi Mollapour · 2022 · Sub-cellular biochemistry/Subcellular biochemistry
  51. Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities
    Wen Wen, Jiadong Hu, Chenxi Wang, Rui Yang, Yabo Zhang, Baibei Huang, Tingting Qiao, Jiayun Wang, Xin Chen · 2024 · Bioorganic & Medicinal Chemistry Letters
  52. The Major Capsid Protein, VP1, of the Mouse Polyomavirus Stimulates the Activity of Tubulin Acetyltransferase 1 by Microtubule Stabilization
    Lenka Horníková, Kateřina Bruštíková, Boris Ryabchenko, Ilia Zhernov, Martin Fraiberk, Zuzana Mariničová, Zdeněk Lánský, Jitka Forstová · 2020 · Viruses
  53. Histone Deacetylase Inhibitors in Cancer Therapy
    Yen‐Shen Lu, Ching‐Shih Chen, Ann‐Lii Cheng, Aaron M. Sargeant, Samuel Kiyota Kulp · 2008 · CRC Press eBooks
  54. Renal ciliopathies
    Laura Alice Devlin, Rebecca Marie Dewhurst, Praveen Dhondurao Sudhindar, John Andrew Sayer · 2025 · Current topics in developmental biology/Current Topics in Developmental Biology
  55. HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models
    Ilinca M. Giosan, Randal A. Serafini, Aarthi Ramakrishnan, Madden J. Tuffy, Jeffrey H. Zimering, Alexandru Babeș, Li Shen, Venetia Zachariou · 2025 · Molecular Pharmacology
  56. Histone deacetylase 6: a potential therapeutic target for drug development
    Zitong Li, Huan Zhu, Xiaojing Wang, Lihui Zhang, Lei Zhang · 2025 · Bioorganic Chemistry
  57. Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro
    Lulu Si, Tianjiao Lai, Junru Zhao, Yuxi Jin, Meng Qi, Mingyue Li, Hanlin Fu, Xiaojing Shi, Liying Ma, Ruixia Guo · 2022 · Frontiers in Pharmacology
  58. HDAC6 inhibitor loaded bimetallene nanosheets with antagonizing thermoresistance for augmented mild photothermal therapy
    Lingyu Qiu, Lei Shan, Jing Zhang, Ruhan Yan, Wansi Chen, Jing Lin, Wei‐Guo Zhu, Peng Huang · 2023 · Chinese Chemical Letters
  59. Nafamostat mesilate prevented caerulein-induced pancreatic injury by targeting HDAC6-mediated NLRP3 inflammasome activation
    Peng Chen, Lijun Zhao, Ling Huang, Wenqi He, Ying-Rui Tang, Yi Liu, Jiandong Ren · 2023 · Inflammation Research
  60. ClassIIb histone deacetylase participates in perioperative neurocognitive disorders in elderly mice via HSP90/GR signaling pathway
    Yu Liu, Xinlin Wang, Jiao Wang, Qiqi Jin, Weicha Cai, Chi Pan, John Nivar, Yuan‐Xiang Tao, Hong Cao, Jun Li · 2024 · Experimental Neurology
  61. SARS-CoV-2 nucleocapsid protein promotes self-deacetylation by inducing HDAC6 to facilitate viral replication
    Arpita Mukherjee, Mahadeb Lo, Pritam Chandra, Ratul Datta Chaudhuri, Papiya De, Shanta Dutta, Mamta Chawla‐Sarkar · 2024 · Virology Journal
  62. The rat glucocorticoid receptor integration in Nicotiana langsdorffii genome affects plant responses to abiotic stresses and to arbuscular mycorrhizal symbiosis
    Patrizia Bogani, Elisa Calistri, Stefano Biricolti, Monica Ruffini Castiglione, Alessandra Turrini, Manuela Giovannetti, Marco Buiatti · 2015 · Plant Biotechnology Reports
  63. Epigenetic Targets in Human Neoplasms
    Tamer E. Fandy, Steven D. Gore · 2010 · Epigenomics
  64. Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors
    Lei Zhang, Xuejian Wang, Xiaoguang Li, Lihui Zhang, Wenfang Xu · 2013 · Journal of Enzyme Inhibition and Medicinal Chemistry
  65. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells
    Dengwen Li, Xiaodong Sun, Linlin Zhang, Bing Yan, Songbo Xie, Ruming Liu, Min Liu, Jun Zhou · 2013 · Protein & Cell
  66. Identification of a chaperone-code responsible for Rad51-mediated genome repair
    Khushboo Rani, Akanksha Gotmare, Andreas Maier, Ruchira Menghal, Nashat Akhtar, Nupur Fangaria, Johannes Büchner, Sunanda Bhattacharyya · 2024 · Journal of Biological Chemistry
  67. Liver Cancer (Hepatocellular Carcinoma)
    Shane O’Grady, Matthew W. Lawless · 2015 · Elsevier eBooks
  68. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma
    Syed Farhan Zafar, Ganji Purnachandra Nagaraju, Bassel F. El‐Rayes · 2012 · Expert Opinion on Therapeutic Targets
  69. “Tuning” the ATPase Activity of Hsp90
    C. Prodromou, R. M. Morgan · 2016 · Springer eBooks
  70. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach
    Amir Zeb, Chanin Park, Minky Son, Shailima DV Rampogu, Syed Ibrar Alam, Seok Ju Park, Keun Woo Lee · 2018 · Journal of Bioinformatics and Computational Biology
  71. A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor
    Muhammad Hanif, Jahan Zaib Arshad, Jonathan W. Astin, Zohaib Rana, Ayesha Zafar, Sanam Movassaghi, Euphemia Yee Leung, Kamal D. Patel, Tilo Söhnel, Jóhannes Reynisson et al. · 2020 · Angewandte Chemie
  72. The Emerging Role of Histone Deacetylases (HDACs) in UPR Regulation
    Soumen Kahali, Bhaswati Sarcar, Prakash Chinnaiyan · 2011 · Methods in enzymology on CD-ROM/Methods in enzymology
  73. Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders
    Jonathan M. van Eyll, Robert Ciarán Prior, Sylvain Célanire, Ludo Van Den Bosch, Frederik J. R. Rombouts · 2024 · Expert Opinion on Therapeutic Targets
  74. Scaffolding Activities of Pseudodeacetylase HDAC7
    Ishadi K. M. Kodikara, Mary Kay H. Pflum · 2025 · ACS Chemical Biology
  75. Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer
    Liang Yan, Yong Sun, Shanshan Shi, Yuan Li, Yifan Zhang, Liang-zhuo Qu, Jing Liu, Yong Dai, Qingbing Zha, Jun Fan · 2025 · Journal of Translational Medicine
  76. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6
    Irving Balbuena-Rebolledo, Astrid M. Rivera-Antonio, Yudibeth Sixto‐López, José Correa‐Basurto, Martha Cecilia Rosales‐Hernández, Jessica Elena Mendieta‐Wejebe, Francisco J. Martı́nez-Martı́nez, Ivonne María Olivares-Corichi, José Rubén García-Sánchez, Juan Alberto Guevara‐Salazar et al. · 2022 · Pharmaceuticals
  77. HDAC6 preserves BNIP3 expression and mitochondrial integrity by deacetylating p53 at lysine 320
    Se-In Lee, Yuri Seo, Hoang Oanh, Hyeonbin Go, Hyeonbin Go, Myung hun Kim, Joo‐Yong Lee · 2023 · Biochemical and Biophysical Research Communications
  78. Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stability
    Simon Scheuerer, L. Motlova, Linda Schäker‐Hübner, Andreas Sellmer, Felix Feller, Fabian J. Ertl, Pierre Koch, Finn Kristian Hansen, Cyril Bařinka, Siavosh Mahboobi · 2024 · European Journal of Medicinal Chemistry
  79. The rabies virus matrix protein (RABV M) interacts with host histone deacetylase 6 (HDAC6) to activate the MEK/ ERK signaling pathway and enhance viral replication
    Juanbin Yin, Shasha Wang, Zhixiong Zhang, Junwei Ge, Zhang Qiang, Yuefeng Sun, Xiangping Yin, Xiangwei Wang · 2025 · Veterinary Microbiology
  80. Hsp90 as a therapeutic target in endocrinology: current evidence
    T. Ratajczak, Bryan K. Ward, John P. Walsh, Carmel Cluning · 2015 · Research and Reports in Endocrine Disorders
  81. Differences in Functional Expression of Connexin43 and NaV1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in Heart
    Xian Zhang, Dakshesh Patel, Qin Xu, Richard D. Veenstra · 2018 · International Journal of Molecular Sciences
  82. Identification of a histone deacetylase inhibitor as a therapeutic candidate for congenital central hypoventilation syndrome
    Chiara Africano, Tiziana Bachetti, Paolo Uva, Gabriel Pitollat, Genny Del Zotto, Francesca Giacopelli, Giada Recchi, Nicolas Lenfant, Amélia Madani, Nathan Beckouche et al. · 2024 · Molecular Therapy — Nucleic Acids
  83. Determination of Protein Lysine Deacetylation
    Danielle J.P. Ellis, Zhigang Yuan, Edward Seto · 2008 · Current Protocols in Protein Science
  84. Cancer Epigenetics
    Lee B. Riley, David W. Anderson · 2010 · Elsevier eBooks
  85. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells
    Rie Hagiwara, Kazunori Kageyama, Yasumasa Iwasaki, Kanako Niioka, Makoto Daimon · 2022 · Endocrine Journal
  86. The Potential of Histone Deacetylase Inhibitors in Lung Cancer
    Ana M. Aparicio · 2006 · Clinical Lung Cancer
  87. Neural-Immune Interactions
    Cherié L. Butts, Esther M. Sternberg · 2012 · Elsevier eBooks
  88. Regulation of organic anion transporting polypeptide 1B1 transport function by concurrent phosphorylation and lysine-acetylation: A novel posttranslational regulation mechanism
    Vishakha Tambe, Erik J. Soderblom, Ruhul Kayesh, Vikram Aditya, Chao Xu, Wei Yue · 2024 · Molecular Pharmacology
  89. Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges
    Baiyun Dang, Hou Chen, Shiru Liu, Haijuan Liu, Zhiwen Kang, Zhen Yang, Weixia Yang, Jiadong Hu, Xin Chen · 2025 · Bioorganic & Medicinal Chemistry Letters
  90. The role of HDAC6 in fibrosis: a novel and effective therapy strategy
    Liangliang Zheng, Xiaoyan Zhu, Jiankui Du, Yujian Liu · 2025 · European journal of medical research
  91. Minireview: The Versatile Roles of Lysine Deacetylases in Steroid Receptor Signaling
    Vineela Kadiyala, Catharine L. Smith · 2014 · Molecular Endocrinology
  92. Targeting chaperone modifications: Innovative approaches to cancer treatment
    Mariah S. Stewart, Jonathan Cummings Schisler · 2024 · Journal of Biological Chemistry
  93. HDAC6: Tumor Progression and Beyond
    João Marcos Oliveira‐Silva, Leilane Sales Oliveira, João Vitor Marangoni Tagliéri, Laís Bernardo Lopes, Carlos Vinicius Expedito de Souza, Hanna Karolina de Araújo Batistão, Angel Maurício Castro‐Gamero · 2025 · Current Cancer Drug Targets
  94. Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer
    Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Serena I. Valsami, Dimitrios Dimitroulis · 2019 · Elsevier eBooks
  95. Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824
    Maria V. Yusenko, Karl‐Heinz Klempnauer · 2021 · BBA Advances
  96. MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer
    Xu Zhang, Yang Yang, Danyang Li, Zhen Wu, Haoyu Liu, Ziyan Zhao, Hongying Zhu, Fei Xie, Xiangzhi Li · 2022 · Frontiers in Oncology
  97. Machine Learning Approaches to Predict the Selectivity of Compounds against HDAC1 and HDAC6
    Berna Doğan · 2024 · Journal of Computational Biophysics and Chemistry
  98. HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents
    Jie Peng, Hongyan Liu, Yujing Liu, Jingqian Liu, Qianlong Zhao, Wenjia Liu, Haoqian Niu, Haoyu Xue, Jie Sun, Jingde Wu · 2024 · Bioorganic Chemistry
  99. Finding the place of histone deacetylase inhibitors in prostate cancer therapy
    D.L. Marrocco, Margaret M. Centenera, Howard I. Scher, Wayne D. Tilley, Lisa M. Butler · 2009 · Expert Review of Clinical Pharmacology
  100. Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer
    Juliana Felgueiras · 2014 · World Journal of Pharmacology